Cargando…
The effects of releasing early results from ongoing clinical trials
Most trials do not release interim summaries on efficacy and toxicity of the experimental treatments being tested, with this information only released to the public after the trial has ended. While early release of clinical trial data to physicians and patients can inform enrollment decision making,...
Autores principales: | Ventz, Steffen, Bacallado, Sergio, Rahman, Rifaquat, Tolaney, Sara, Schoenfeld, Jonathan D., Alexander, Brian M., Trippa, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864990/ https://www.ncbi.nlm.nih.gov/pubmed/33547324 http://dx.doi.org/10.1038/s41467-021-21116-4 |
Ejemplares similares
-
The design and evaluation of hybrid controlled trials that leverage external data and randomization
por: Ventz, Steffen, et al.
Publicado: (2022) -
A quantitative framework for modeling COVID-19 risk during adjuvant therapy using published randomized trials of glioblastoma in the elderly
por: Tabrizi, Shervin, et al.
Publicado: (2020) -
KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials
por: Fell, Geoffrey, et al.
Publicado: (2021) -
Looking ahead in early-phase trial design to improve the drug development process: examples in oncology
por: Vanderbeek, Alyssa M., et al.
Publicado: (2023) -
Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials
por: Tabrizi, Shervin, et al.
Publicado: (2021)